News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
334,054 Results
Type
Article (23240)
Company Profile (304)
Press Release (310510)
Multimedia
Podcasts (52)
Webinars (7)
Section
Business (95287)
Career Advice (1324)
Deals (16140)
Drug Delivery (65)
Drug Development (55345)
Employer Resources (95)
FDA (7289)
Job Trends (6776)
News (171030)
Policy (13291)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (2)
2024 BioMidwest Digital (5)
2024 Bio NC Digital (5)
2024 Biotech Bay Standard (13)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1426)
Accelerated approval (3)
Adcomms (21)
Allergies (60)
Alliances (25520)
ALS (68)
Alzheimer's disease (1011)
Antibody-drug conjugate (ADC) (111)
Approvals (7289)
Artificial intelligence (160)
Autoimmune disease (21)
Automation (5)
Bankruptcy (133)
Best Places to Work (5825)
BIOSECURE Act (10)
Biosimilars (67)
Biotechnology (252)
Bladder cancer (70)
Brain cancer (22)
Breast cancer (193)
Cancer (1666)
Cardiovascular disease (142)
Career advice (1095)
Career pathing (19)
CAR-T (129)
Cell therapy (355)
Cervical cancer (9)
Clinical research (44692)
Collaboration (600)
Compensation (265)
Complete response letters (19)
COVID-19 (1609)
CRISPR (41)
C-suite (182)
Cystic fibrosis (79)
Data (1648)
Decentralized trials (1)
Denatured (11)
Depression (41)
Diabetes (181)
Diagnostics (2694)
Digital health (6)
Diversity (3)
Diversity, equity & inclusion (24)
Drug discovery (97)
Drug pricing (69)
Drug shortages (15)
Duchenne muscular dystrophy (93)
Earnings (36518)
Editorial (35)
Employer branding (13)
Employer resources (87)
Events (54793)
Executive appointments (501)
FDA (8098)
Featured Employer (33)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (554)
Gene editing (97)
Generative AI (14)
Gene therapy (272)
GLP-1 (487)
Government (1804)
Grass and pollen (2)
Guidances (35)
Healthcare (8840)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (113)
Indications (21)
Infectious disease (1693)
Inflammatory bowel disease (125)
Inflation Reduction Act (9)
Influenza (25)
Intellectual property (69)
Interviews (275)
IPO (8529)
IRA (31)
Job creations (1285)
Job search strategy (885)
Kidney cancer (10)
Labor market (16)
Layoffs (279)
Leadership (17)
Legal (2184)
Liver cancer (36)
Lung cancer (238)
Lymphoma (110)
Machine learning (5)
Management (32)
Manufacturing (185)
MASH (58)
Medical device (4310)
Medtech (4311)
Mergers & acquisitions (7987)
Metabolic disorders (500)
Multiple sclerosis (60)
NASH (15)
Neurodegenerative disease (87)
Neuropsychiatric disorders (28)
Neuroscience (1477)
NextGen: Class of 2025 (2922)
Non-profit (1509)
Northern California (1827)
Now hiring (22)
Obesity (266)
Opinion (200)
Ovarian cancer (64)
Pain (57)
Pancreatic cancer (61)
Parkinson's disease (133)
Partnered (14)
Patents (140)
Patient recruitment (84)
Peanut (39)
People (29493)
Pharmaceutical (49)
Pharmacy benefit managers (14)
Phase I (15225)
Phase II (20556)
Phase III (13724)
Pipeline (884)
Policy (100)
Postmarket research (1092)
Preclinical (6481)
Press Release (33)
Prostate cancer (73)
Psychedelics (37)
Radiopharmaceuticals (226)
Rare diseases (324)
Real estate (1914)
Recruiting (41)
Regulatory (10629)
Reports (21)
Research institute (1297)
Resumes & cover letters (233)
Rett syndrome (4)
RNA editing (5)
RSV (17)
Schizophrenia (67)
Series A (105)
Series B (67)
Service/supplier (1)
Sickle cell disease (44)
Southern California (1595)
Special edition (13)
Spinal muscular atrophy (129)
Sponsored (24)
Startups (2250)
State (1)
Stomach cancer (11)
Supply chain (35)
Tariffs (22)
The Weekly (40)
United States (14655)
Vaccines (362)
Venture capitalists (36)
Weight loss (177)
Women's health (21)
Worklife (10)
Date
Today (100)
Last 7 days (549)
Last 30 days (1723)
Last 365 days (21929)
2025 (6986)
2024 (23072)
2023 (25349)
2022 (33394)
2021 (34554)
2020 (30199)
2019 (21668)
2018 (15929)
2017 (16833)
2016 (15057)
2015 (17986)
2014 (13130)
2013 (9497)
2012 (9776)
2011 (9965)
2010 (9204)
Location
Africa (389)
Alabama (42)
Alaska (2)
Arizona (64)
Arkansas (9)
Asia (20268)
Australia (3677)
California (4169)
Canada (1247)
China (406)
Colorado (162)
Connecticut (174)
Delaware (109)
Europe (45236)
Florida (502)
Georgia (129)
Idaho (24)
Illinois (277)
India (15)
Indiana (162)
Iowa (4)
Japan (98)
Kansas (69)
Kentucky (6)
Louisiana (3)
Maine (20)
Maryland (551)
Massachusetts (3287)
Michigan (107)
Minnesota (184)
Mississippi (1)
Missouri (41)
Montana (16)
Nebraska (6)
Nevada (21)
New Hampshire (20)
New Jersey (1057)
New Mexico (12)
New York (1153)
North Carolina (609)
North Dakota (5)
Northern California (1827)
Ohio (130)
Oklahoma (10)
Oregon (24)
Pennsylvania (812)
Puerto Rico (6)
Rhode Island (20)
South America (470)
South Carolina (8)
Southern California (1595)
Tennessee (35)
Texas (499)
Utah (87)
Virginia (86)
Washington D.C. (41)
Washington State (363)
West Virginia (2)
Wisconsin (23)
334,054 Results for "turning point therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Bluebird Faces Cash Gap With Breakeven Point in Sight
Bluebird has just two quarters until it’s out of cash. Executives are looking for financing to extend that runway to a projected breakeven point before the end of 2025, with analysts worried they won’t make it.
November 15, 2024
·
4 min read
·
Annalee Armstrong
Press Releases
AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™
April 22, 2025
·
3 min read
Biotech Beach
Turn Therapeutics Atopic Dermatitis Candidate Reduces Disease Severity by 57% In-Vivo
In a widely cited in-vivo model of atopic dermatitis, Turn Therapeutics’ atopic dermatitis candidate showed a dramatic reduction in disease severity versus placebo.
June 20, 2024
·
2 min read
Press Releases
SEKISUI Diagnostics to Provide Metrix® COVID/Flu Test to the Point-of-Care and Home Test Markets
April 3, 2025
·
3 min read
Press Releases
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
May 1, 2025
·
6 min read
Editorial
This Might Be a Moot Point but the FDA’s Priority Review Vouchers Need Transparency
While Congress is renewing the priority review voucher program for rare pediatric diseases, the FDA should be required to keep public records of the passes changing hands, too.
March 7, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Equipment Junction Turns Surplus Lab Gear into STEM Opportunities
April 1, 2025
·
1 min read
Press Releases
Transverse Medical Inc. Announces Completion of First Series of Patients in Feasibility Clinical Study at Victorian Heart Hospital, Melbourne, Australia, Using Point-Guard Cerebral Embolic Protection.
April 21, 2025
·
4 min read
Press Releases
Cagent Vascular Initiates the Serranator® POINT FORCE Observational Registry
January 28, 2025
·
2 min read
Deals
Bristol Myers Squibb Completes Acquisition of Turning Point Therapeutics, Expanding Precision Oncology Portfolio
Bristol Myers Squibb (NYSE:BMY) announced today that it has successfully completed its acquisition of Turning Point Therapeutics, Inc. (“Turning Point”), in an all-cash transaction.
August 17, 2022
·
6 min read
1 of 33,406
Next
